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Objectives. The purpose of the study was to analyze the factors
that favor the occurrence of sustained monomorphic ventricular
tachycardia in the early phase (<48 h) of acute myocardial
infarction and to establish its prognostic implications.
Background. Sustained monomorphic ventricular tachycardia
early in the course of an acute myocardial infarction is an
uncommon arrhythmia, and its signiﬁcance has not been specif-
ically studied.
Methods. The clinical characteristics and prognosis of sus-
tained monomorphic ventricular tachycardia were studied in 21
(1.9%) of 1,120 consecutive patients admitted to the coronary care
unit with a diagnosis of myocardial infarction.
Results. Patients with sustained monomorphic ventricular
tachycardia had a larger infarct on the basis of peak creatine
kinase, MB fraction (CK-MB) isoenzyme activity (435  253
IU/liter vs. 168  145 IU/liter, p < 0.001) and higher mortality
rate (43% vs. 11%, p < 0.001). By logistic regression analysis,
independent predictors of sustained monomorphic ventricular
tachycardia were CK-MB (odds ratio [OR] 11.8), Killip class (OR
4.0) and bifascicular bundle branch block (OR 3.1). Moreover,
sustained monomorphic ventricular tachycardia was itself an
independent predictor of mortality (OR 5.0). Compared with
patients with ventricular ﬁbrillation, those with sustained mono-
morphic ventricular tachycardia had a worse Killip class (Killip
class >I: 63% vs. 30%, p < 0.05), higher CK-MB activity (430 
260 IU/liter vs. 242  176 IU/liter, p < 0.01) and higher
arrhythmia recurrence rate (31% vs. 4%, p < 0.01). During the
follow-up period, 5 (42%) of 12 survivors in the sustained mono-
morphic ventricular tachycardia group died of cardiac-related
causes. Recurrence of ventricular tachycardia was seen in two
patients (17%).
Conclusions. Sustained monomorphic ventricular tachycardia
during the ﬁrst 48 h of myocardial infarction is a sign of extensive
myocardial damage and an independent predictor of in-hospital
mortality.
(J Am Coll Cardiol 1996;28:1670–6)
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The prognosis and the electrophysiologic mechanisms of
sustained monomorphic ventricular tachycardia occurring in
the subacute and chronic phases of myocardial infarction
have been extensively investigated in patients and in exper-
imental models (1,2). However, knowledge of the predispos-
ing factors and the prognosis of sustained monomorphic
ventricular tachycardia occurring during the ﬁrst 48 h of
myocardial infarction is very limited. Previous experimental
data from our laboratory support the concept that sponta-
neous, sustained monomorphic ventricular tachycardia oc-
curs in large myocardial infarctions (3). In contrast, the
majority of clinical studies dealing with ventricular arrhyth-
mias during the early phase of myocardial infarction are
focused on ventricular ﬁbrillation (4,5) or have considered
ventricular tachycardia and ventricular ﬁbrillation together
(6–8). To our knowledge, only one study has analyzed the
prognostic value of sustained ventricular tachycardia in the
acute phase of myocardial infarction (9), but patients with
hemodynamic compromise were excluded. Furthermore, no
studies comparing patients suffering from sustained mono-
morphic ventricular tachycardia with those presenting with
ventricular ﬁbrillation have been reported. Such a compar-
ison may be relevant because several investigators have
demonstrated that the characteristics and the arrhythmo-
genic substrate of patients with sustained monomorphic
ventricular tachycardia in the chronic phase of infarction are
different from those with ventricular ﬁbrillation (10,11).
The aim of the study was to analyze the clinical character-
istics and the prognosis of patients with sustained monomor-
phic ventricular tachycardia during the early phase of myocar-
dial infarction. In addition, we compared the clinical variables
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of these patients with those from patients with ventricular
ﬁbrillation.
Methods
Patients. From January 1991 to January 1995, 1,124 pa-
tients with acute myocardial infarction were admitted to the
coronary care unit (CCU) of our hospital. Readmissions to the
CCU because of a reinfarction episode during follow-up
occurred in 36 patients, but these episodes of reinfarction were
not included in the analysis.
Data collection. Data on demographic and clinical charac-
teristics, laboratory results and complications during the hos-
pital stay were collected prospectively in a specially designed
form. The diagnosis of myocardial infarction was based on
clinical symptoms, evolving electrocardiographic (ECG)
changes and serial elevation of total creatine kinase (CK) and
CK-MB fraction isoenzyme (MB-CK) activity. Continuous
ECG monitoring was started in the emergency room and was
continued throughout the patients’ stay in the CCU. Lidocaine
was not administered prophylactically. Patients with sustained
monomorphic ventricular tachycardia during the acute phase
of infarction were followed up at the outpatient clinic. None of
them was discharged on antiarrhythmic drugs, and they were
not submitted to an electrophysiologic study.
To provide a comparative estimation of follow-up mortality
among patients without sustained monomorphic ventricular
tachycardia, we analyzed data from an institutional registry
that began in April 1994 and included the last 167 patients of
this nontachycardia group.
Deﬁnitions. Sustained monomorphic ventricular tachycardia
was deﬁned as a wide QRS (120 ms) tachycardia with a
uniform QRS conﬁguration in at least one ECG monitor lead,
and a constant cycle length that lasted longer than 30 s or
provoked hemodynamic collapse.
For the purpose of the study, episodes of ventricular ﬁbril-
lation that took place as a degeneration of a fast monomorphic
ventricular tachycardia were not included in the ventricular
ﬁbrillation group. Also, patients who recovered from ventric-
ular ﬁbrillation outside the hospital were excluded because the
initiating arrhythmia might have been a sustained monomor-
phic ventricular tachycardia. We did not consider an episode of
ventricular ﬁbrillation if it occurred as the ﬁnal event of a
cardiogenic shock.
Statistical analysis. Data are expressed as the mean
value SD. Differences among groups were assessed using the
chi-square test for qualitative variables and the Student t test
for continuous variables. Logistic regression analysis was per-
formed using forward stepwise selection and the method of the
likelihood ratio test to obtain the model that better explained
the occurrence of sustained monomorphic ventricular tachy-
cardia and the model that better predicted in-hospital
mortality—the dependent variables in both cases. CK-MB
activity was transformed into a dichotomic variable according
to the best sensitivity and speciﬁcity to predict the event using
the receiver operating characteristic curves (12). Two different
cutoff points were chosen: one for the prediction of sustained
monomorphic ventricular tachycardia with a CK-MB activity of
350 IU/liter and another for the prediction of mortality with a
CK-MB activity of 100 IU/liter. The level of statistical signiﬁ-
cance was p  0.05. Statistical analysis was performed using
the SPSS package (13).
Results
Among the 1,124 consecutive patients admitted with the
diagnosis of myocardial infarction, 25 presented a sustained
ventricular tachycardia during the ﬁrst 48 h of infarction. Four
of them were excluded from the analysis (one patient because
the tachycardia was polymorphic and three because of incom-
plete evidence of the monomorphism of the QRS complex
during tachycardia). Therefore, the frequency of sustained
monomorphic ventricular tachycardia in the very early phase of
myocardial infarction was 1.9% (21 of 1,120 patients). A
12-lead ECG during tachycardia could be obtained in 7 of the
21 patients.
Figure 1 depicts an example of a sustained monomorphic
ventricular tachycardia in a patient with an extensive anterior
myocardial infarction. Table 1 shows the clinical data from the
21 patients with sustained monomorphic ventricular tachycar-
dia. Patients with this arrhythmia had a high peak CK and
Abbreviations and Acronyms
CCC  coronary care unit
CK  creatine kinase
CK-MB  creatine kinase, MB fraction
ECG  electrocardiogram, electrocardiographic
Figure 1. Twelve-lead ECG from Patient 5, who had an acute anterior
myocardial infarction (A) complicated by an episode of sustained
monomorphic ventricular tachycardia occurring 2 h after the onset of
infarction (B).
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CK-MB isoenzyme activity and a low ejection fraction, al-
though some data were not available in patients who died early
in the course of myocardial infarction. Nine (42%) of the
sustained monomorphic ventricular tachycardia episodes took
place during the ﬁrst 4 h of the infarction. Three of these
nine episodes occurred during or immediately after throm-
bolysis. Of the 21 index episodes, 15 (71%) occurred during
the ﬁrst 12 h. Eight patients (38%) were in Killip class III or
IV when the index episode of sustained monomorphic
ventricular tachycardia took place. The tachycardia rate was
173  38 beats/min (range 120 to 250). Circulatory arrest
was seen in eight patients (38%) during the index episode of
tachycardia and cardioversion was required in 16 patients
(76%), whereas in ﬁve patients the arrhythmia was con-
trolled by intravenous antiarrhythmic drugs. One patient
died during the index episode, two patients died because of
recurrent episodes of ventricular tachycardia in the same
day, ﬁve patients died because of cardiogenic shock and one
patient died from a late cardiac rupture.
Univariate analysis for sustained monomorphic ventricular
tachycardia. Table 2 shows the results of the univariate anal-
ysis comparing the characteristics of patients with and without
sustained monomorphic ventricular tachycardia. No differ-
ences in age, gender distribution or risk factors were observed.
Patients with sustained monomorphic ventricular tachycardia
had larger infarctions than patients without sustained mono-
morphic ventricular tachycardia, as judged by their higher peak
CK-MB isoenzyme activity, worse Killip class at admission,
higher frequency of anterior wall infarctions, higher frequency
of bifascicular bundle branch block and lower ejection fraction.
Patients with ventricular tachycardia more often received
Table 1. Clinical Characteristics of Patients With Sustained Monomorphic Ventricular Tachycardia
Pt. No./Gender
Age
(yr) Loc
CK
(IU/liter)
CK-MB
(IU/liter) Thromb
Delay
(h)*
Killip
Class†
Time
(h)‡
EF
(%) Death§ Follow-Up Event
1/M 69 Ant 2,119 177 SK 2 I 2.30 33 — AMI, CABG, SMVT, dead
2/M 65 Ant 2,229 442 None — III  1 — Shock —
3/F 79 Ant 3,122 378 None — II 6 — Arrhyth —
4/M 52 Ant 3,822 301 t-PA 2 II 1 30 — No events
5/M 57 Ant 5,652 754 t-PA 2 III 2 20 Rupture —
6/M 58 Ant 3,948 416 SK 2 I 24 35 — Angina
7/M 45 Inf 3,696 449 SK 5 I 44 35 — No events
8/F 40 Inf — — None — IV 9 — Arrhyth —
9/F 67 Ant 6,018 783 t-PA 4 IV 1 — Shock —
10/M 53 Ant 3,822 301 None — II 1 30 — AMI, HF, dead
11/M 57 Inf 4,974 824 None — I 2 35 — HF, SMVT, dead
12/M 76 Ant 1,506 409 t-PA 2 III 1 24 — AMI, HF, dead
13/M 74 Ant 5,000 1,521 t-PA 2 II 12 — Arrhyth —
14/M 49 Inf 2,448 240 SK 3 II 3 46 — HF
15/M 57 Ant 1,984 232 SK 3 I 10 — — No events
16/M 57 Inf — — None — I 30 — Shock —
17/F 73 Ant 2,592 444 None — III 7 33 — HF
18/M 65 Ant 4,845 605 SK 3 IV 38 — Shock —
19/M 50 Ant 4,662 448 SK 3 I 42 46 — No events
20/M 75 Ant 611 104 None — II 40 30 — AMI, dead
21/M 69 Ant 5,310 528 None — IV 6 — Shock —
*Time from onset of symptoms to onset of thrombolysis. †Killip class at admission. ‡Time of occurrence of ventricular tachycardia after onset of infarction. §Cause
of in-hospital death. AMI acute myocardial infarction; Ant anterior wall myocardial infarction; Arrhyth death due to ventricular arrhythmia; CABG coronary
artery bypass graft surgery; CK creatine kinase; CK-MB creatine kinase, MB fraction; EF ejection fraction; HF readmission due to heart failure; Inf inferior
wall myocardial infarction; Loc  localization of infarction; SK  streptokinase; SMVT  episode of sustained monomorphic ventricular tachycardia; Thromb 
thrombolysis; t-PA  tissue-type plasminogen activator; —  data not available or applicable.
Table 2. Clinical Characteristics, Complications and Mortality in
Patients With and Without Sustained Monomorphic
Ventricular Tachycardia
No SMVT
(n  1,099)
SMVT
(n  21) p Value
Male/female 846/253 17/4 0.66
Age (yr) 61  10 61  11 0.97
Hypertension 488 (44%) 8 (38%) 0.56
Smoker 700 (64%) 16 (76%) 0.23
Diabetes 274 (25%) 4 (19%) 0.54
Previous angina 427 (39%) 7 (33%) 0.61
Previous MI 210 (19%) 5 (23%) 0.59
Ant 409 (37%) 16 (76%)  0.001
Inf 433 (40%) 5 (23%)  0.02
Thromb 343 (31%) 11 (52%)  0.04
Killip class I 244 (22%) 13 (62%)  0.001
CK (IU/liter) 1,573  1,457 3,668  1,559  0.001
CK-MB (IU/liter) 168  145 435  253  0.001
Bifascicular BBB 92 (8%) 8 (38%)  0.001
AV block 74 (7%) 4 (19%)  0.05
VF 33 (3%) 2 (10%) 0.08
EF 50  14% 37  12%  0.001
In-hospital death 126 (11%) 9 (43%)  0.001
Data presented are mean value  SD, number of patients or number (%) of
patients. AV  atrioventricular; BBB  bundle branch block; MI  myocardial
infarction; VF  ventricular ﬁbrillation; other abbreviations as in Table 1.
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thrombolytic therapy than their counterparts, and they had a
higher mortality than those without sustained monomorphic
ventricular tachycardia (43% vs. 11%). There were no differ-
ences in the characteristics of sustained monomorphic ventric-
ular tachycardia (rate and time of presentation) between
patients with and without thrombolysis.
Logistic regression analysis for prediction of sustained
monomorphic ventricular tachycardia. As shown in Table 3,
among a set of 10 variables included in the logistic regression
analysis (age, previous angina, diabetes, gender, hypertension,
prior myocardial infarction, anterior myocardial infarction,
Killip class, bifascicular block and CK-MB activity), only the
following three variables were chosen as independent predic-
tors of the occurrence of sustained monomorphic ventricular
tachycardia: 1) CK-MB activity 350 IU/liter; 2) Killip class
I; and 3) bifascicular bundle branch block. When these three
conditions were present, the probability of developing sus-
tained monomorphic ventricular tachycardia was 35.5%.
Univariate analysis for in-hospital mortality. Table 4
shows the comparison among survivors and patients who died
during their hospital stay. All comparisons demonstrated sta-
tistical differences among groups with a borderline statistical
signiﬁcance for a previous infarction. The presence of sus-
tained monomorphic ventricular tachycardia was less frequent
in survivors (1%) than in those who died during their hospital
stay (7%).
Logistic regression analysis for prediction of mortality. As
depicted in Table 5, 12 variables obtained during the ﬁrst hours
of hospitalization (age, gender, diabetes, hypertension, previ-
ous angina, previous infarction, Killip class, CK-MB activity,
anterior myocardial infarction, bifascicular bundle branch
block, ventricular ﬁbrillation, as well as the presence of sus-
tained monomorphic ventricular tachycardia) were included in
the model of logistic regression analysis. Among these vari-
ables, age, Killip class, presence of sustained monomorphic
ventricular tachycardia, occurrence of ventricular ﬁbrillation,
diabetes, previous angina, and CK-MB activity were selected as
independent predictors of in-hospital mortality. The presence
of sustained monomorphic ventricular tachycardia was an
independent prognostic factor associated with a ﬁvefold in-
crease in mortality.
Comparison between patients with sustained monomorphic
ventricular tachycardia and ventricular ﬁbrillation. Table 6
shows the results of the univariate analysis comparing the
Table 3. Results of Logistic Regression Analysis: Independent
Predictors of Sustained Monomorphic Ventricular
Tachycardia Occurrence
Variable Corr Coeff OR (CI) p Value
Constant 5.53
CK-MB 2.47 11.8 (4.47–31.43)  0.001
Killip class 1.39 4.04 (1.49–10.9)  0.004
Bifascicular BBB 1.14 3.12 (1.08–8.99) 0.04
CI  conﬁdence interval; Corr Coeff  correlation coefﬁcient; OR  odds
ratio; other abbreviations as in Table 2.
Table 4. Univariate Analysis of In-Hospital Death
Alive
(n  985)
Dead
(n  135) p Value
Male/female 781/204 82/53  0.001
Age (yr) 61  10 66  9  0.001
Hypertension 423 (43%) 73 (54%)  0.05
Smoker 659 (67%) 57 (42%)  0.001
Diabetes 227 (23%) 57 (42%)  0.001
Previous angina 366 (37%) 68 (50%)  0.001
Previous MI 181 (18%) 34 (25%) 0.06
Ant 353 (36%) 72 (53%)  0.001
Thromb 316 (32%) 38 (28%) 0.36
Killip class I 169 (17%) 88 (65%)  0.001
CK (IU/liter) 1,561  1,443 2,079  1,777  0.001
CK-MB (IU/liter) 170  149 206  174  0.025
SMVT 12 (1%) 9 (7%)  0.001
VF 28 (3%) 7 (5%) 0.14
Bifascicular BBB 71 (7%) 29 (21%)  0.001
AV block 56 (6%) 22 (16%)  0.001
Data presented are mean value  SD, number of patients or number (%) of
patients. Abbreviations as in Tables 1 and 2.
Table 5. Results of Logistic Regression Analysis: Independent
Predictors of In-Hospital Death
Variable Corr Coeff OR (CI) p Value
Constant 6.19
Killip class 1.77 5.89 (3.68–9.41) 0.001
SMVT 1.61 5.0 (1.63–15.3) 0.004
VF 1.11 3.06 (1.14–8.19) 0.02
Diabetes 0.99 2.69 (1.67–4.32)  0.001
Angina 0.72 2.06 (1.3–3.26) 0.019
CK-MB 0.67 1.95 (1.19–5.21) 0.008
Age 0.033 1.03 (1.00–1.06) 0.013
Abbreviations as in Tables 1 to 3.
Table 6. Comparison of Patients With Sustained Monomorphic
Ventricular Tachycardia and Those With Ventricular Fibrillation
SMVT (n  19) VF (n  27) p Value
Male/female 15/4 22/5 0.83
Age (yr) 61  11 60  8 0.65
Hypertension 8 (42%) 13 (48%) 0.68
Smoker 15 (79%) 19 (71%) 0.51
Previous angina 7 (37%) 7 (26%) 0.43
Previous MI 5 (26%) 4 (15%) 0.33
Ant 14 (73%) 12 (44%)  0.05
Thromb 10 (53%) 11 (41%) 0.42
Killip class I 12 (63%) 8 (30%)  0.05
CK (IU/liter) 3,481  1,545 2,863  2,069 0.29
CK-MB (IU/liter) 430  260 242  176  0.01
Bifascicular BBB 7 (37%) 5 (19%) 0.16
AV block 3 (16%) 4 (15%) 0.92
EF 36  12 (%) 38  12% 0.72
In-hospital recurrence 6 (31%) 1 (4%)  0.01
In-hospital death 8 (42%) 4 (15%)  0.05
Data presented are mean value  SD, number of patients or number (%) of
patients. Abbreviations as in Tables 1 and 2.
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clinical characteristics of patients with sustained monomorphic
ventricular tachycardia with those with ventricular ﬁbrillation.
Two patients with both arrhythmias were excluded from the
analysis. Furthermore, six patients who had recovered from
ventricular ﬁbrillation before hospital admission were also
excluded because the initiating arrhythmia could have been a
sustained monomorphic ventricular tachycardia. Patients with
sustained monomorphic ventricular tachycardia had larger
infarctions (inferred by their higher CK-MB activity, greater
incidence of anterior wall infarction and worse Killip class),
more arrhythmia recurrences and higher mortality during the
acute phase of infarction than patients with ventricular ﬁbril-
lation. In ﬁve of the six patients with recurrences of sustained
monomorphic ventricular tachycardia, the arrhythmia devel-
oped within 3 h of the index episode, whereas in the remaining
patient the episode occurred 24 h later.
Follow-up of patients with sustained monomorphic ventric-
ular tachycardia. During a mean follow-up of 29 months
(range 2 to 51), 5 (42%) of 12 patients discharged from the
hospital had a cardiac death. Two patients died in cardiogenic
shock after a reinfarction; one had a suspected reinfarction
and died at home; one was admitted with advanced heart
failure and died in cardiogenic shock; and one died periopera-
tively during coronary artery bypass graft surgery. Before the
operation, the last patient had a reinfarction complicated by
three episodes of sustained monomorphic ventricular tachycar-
dia. Another patient had a recurrence of sustained monomor-
phic ventricular tachycardia of a different conﬁguration 15
months after the myocardial infarction without evidence of
reinfarction. The follow-up of the remaining seven surviving
patients is summarized in Table 1. Cardiac mortality in the
subset of 167 patients comprising the control group was 12%
during a mean follow-up of 13 months (range 7 to 17).
Discussion
Main ﬁndings. This study shows that the occurrence of
sustained monomorphic ventricular tachycardia during the
early phase of myocardial infarction is a sign of extensive
myocardial damage and an independent predictor of in-
hospital mortality. Furthermore, when compared with patients
with ventricular ﬁbrillation, patients with sustained monomor-
phic ventricular tachycardia have larger infarctions, a higher
in-hospital recurrence rate of the arrhythmia and a higher
in-hospital mortality. In addition, during the follow-up, pa-
tients with sustained monomorphic ventricular tachycardia had
a high risk of cardiac events but a low probability of arrhythmia
recurrence or sudden death.
Role of infarct size. The inﬂuence of the infarct size on the
development of sustained monomorphic ventricular tachycar-
dia during the early phase of myocardial infarction is not well
known because this arrhythmia has not been analyzed sepa-
rately from ventricular ﬁbrillation (6–8). Only indirect evi-
dence obtained from a study performed by Eldar et al. (9)
suggests that there may be a relation between infarct extension
and occurrence of sustained ventricular tachycardia. In a
multicenter trial involving 2,776 patients, these investigators
separately analyzed patients with sustained ventricular tachy-
cardia in the early phase of myocardial infarction from those
with ventricular ﬁbrillation. In the latter study, only patients
without heart failure were included; thus, the role of infarct
size on the genesis of sustained monomorphic ventricular
tachycardia might have been underestimated. Despite this, the
work by Eldar et al. (9) still suggests a relation between
sustained ventricular tachycardia and infarct size, which may
explain the higher in-hospital mortality in the arrhythmia
group.
Our data indicate that sustained monomorphic ventricular
tachycardia occurred in patients with extensive infarctions
because it was associated with a high peak of CK-MB activity,
heart failure and bifascicular bundle branch block. Further-
more, the ejection fraction of survivors was severely depressed.
Animal models analyzing the role of infarct extension in the
genesis of spontaneous sustained ventricular tachycardia in the
early phase of myocardial infarction are scarce, and there are
no reports in which the polymorphic and monomorphic forms
of tachycardia were studied separately. The work by Bolli et al.
(14) in a dog model of acute ischemia demonstrated that the
presence of prolonged ventricular tachycardia (10 beats/min)
was related to the amount of ischemic myocardium, to the
severity of myocardial ﬂow reduction and to the increase in
heart rate. Our previous observations in a pig model of acute
transmural infarction without reperfusion (3) showed that
spontaneous, sustained monomorphic ventricular tachycardia
occurred in large infarctions induced by the proximal ligature
of the left anterior descending coronary artery, whereas ven-
tricular ﬁbrillation occurred in either the proximal or distal
coronary ligature.
Possible mechanism of sustained monomorphic ventricular
tachycardia. In the subacute and chronic phases of myocardial
infarction, it has been well recognized that reentry through a
stable circuit involving the infarct scar tissue is the most likely
mechanism of sustained monomorphic ventricular tachycardia
(15–17). In contrast, in the very acute phase of a ﬁrst myocar-
dial infarction, when no previous scar tissue is present, the
mechanism of the sustained monomorphic ventricular tachy-
cardia is not known. During acute ischemia, it has been shown
(18,19) that there are zones of slow conduction and block that
may create the conditions for reentry. Our observation that
patients with sustained monomorphic ventricular tachycardia
have large infarcts supports the concept that, even in the
absence of a healed myocardial infarction, a very large acute
ischemic zone may create the conditions for a transiently stable
reentry circuit capable of sustaining a monomorphic reentrant
tachycardia. Alternatively, a focal mechanism linked to a high
sympathetic neural drive or to mechanical stretching (20)
elicited by left ventricular dysfunction could be also consid-
ered.
Prognostic implications. Our data show that patients with
sustained monomorphic ventricular tachycardia had a poor
prognosis and a very high mortality (43%). Moreover, sus-
tained monomorphic ventricular tachycardia during the very
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early phase of myocardial infarction was an independent
predictor of in-hospital mortality, even when other signiﬁcant
prognostic variables were included in the model of regression.
In view of the very high mortality observed in these patients
and also considering that many episodes of sustained mono-
morphic ventricular tachycardia occurred during the ﬁrst 4 h of
infarction, it would probably be advisable to adopt a more
aggressive therapeutic approach in these patients, even con-
sidering the need for emergency catheterization and revascu-
larization through coronary angioplasty.
Differences between sustained monomorphic ventricular
tachycardia and ventricular ﬁbrillation. We have observed
that sustained monomorphic ventricular tachycardia occurred
in a subset of patients different from that of ventricular
ﬁbrillation. Although this concept has been well established in
chronic infarction arrhythmias (10,11), no comparisons have
been made in the acute phase of myocardial infarction. Our
data show that patients with sustained monomorphic ventric-
ular tachycardia had larger infarctions than patients with
ventricular ﬁbrillation. Furthermore, during the hospital stay,
the former group had more recurrences of the arrhythmia and
had a higher mortality rate (42% vs. 15%).
Role of thrombolysis. Although reperfusion arrhythmias
are very prominent in experimental studies (21), they do not
seem to be clinically relevant in patients treated with throm-
bolytic agents (22). The most frequent reperfusion arrhythmias
are ventricular premature beats, accelerated idioventricular
rhythms and nonsustained ventricular tachycardia, rather than
ventricular ﬁbrillation or sustained ventricular tachycardia
(23–27). A meta-analysis of ventricular arrhythmias in throm-
bolytic trials (7) showed that the risk for ventricular ﬁbrillation
is greater in patients receiving placebo than in those treated
with thrombolytic agents, whereas the risk for ventricular
tachycardia was higher in thrombolyzed patients. Nevertheless,
because sustained and nonsustained tachycardias were consid-
ered together, no deﬁnitive conclusions could be drawn. In
patients treated with tissue plasminogen activator, Berger et al.
(6) found a lower patency rate of the infarct-related artery in
cases with ventricular tachycardia or ventricular ﬁbrillation,
suggesting that these arrhythmias are more often associated
with occlusion of the infarct-related artery. Although in our
series there are no data on early patency of the artery, it is very
unlikely that sustained monomorphic ventricular tachycardia
was related with reperfusion. The fact that thrombolytic ther-
apy was more frequently used in the ventricular tachycardia
group was probably due to the higher percentage of transmural
anterior infarctions associated with prominent ST segment
changes. These ECG features promote a higher use of throm-
bolytic agents, as recently demonstrated by Sharkey et al. (28).
Follow-up. Although patients with sustained monomorphic
ventricular tachycardia had a high incidence of cardiac events
and death during follow-up, the risk for arrhythmia recurrence
was low. Moreover, recurrences were much lower than those
observed when sustained monomorphic ventricular tachycar-
dia occurs in patients with chronic infarctions (1).
The poor prognosis of these patients was mainly related to
the impaired ventricular function and to the increased risk for
a new infarction rather than to arrhythmic events. Thus, an
electrophysiologic study to guide further therapeutic interven-
tions may not be necessary.
Study limitations. One of the variables that led us to
conclude that patients with sustained monomorphic ventricu-
lar tachycardia had large infarctions is the observed peak
CK-MB activity; however, because many patients with a sus-
tained monomorphic ventricular tachycardia received cardio-
version this could have increased the CK-MB activity. Never-
theless, it is unlikely that this factor distorted the results,
because CK and CK-MB activity was comparable in patients
with sustained monomorphic ventricular tachycardia treated or
not treated with cardioversion. Furthermore, patients with
sustained monomorphic ventricular tachycardia had a higher
CK-MB activity as compared with patients with ventricular
ﬁbrillation, even though all the patients in the ventricular
ﬁbrillation group were deﬁbrillated. In fact, O’Neill et al. (29),
showed that cardioversion only induces a very slight increase in
CK-MB activity, unless a high number of discharges are
applied. A second limitation of the study is the lack of a 12-lead
ECG during the episode of tachycardia in the 14 patients who
required immediate cardioversion. This fact may theoretically
result in a misinterpretation of a ventricular tachycardia as a
supraventricular tachycardia with aberrant conduction. How-
ever, our assumption that a regular, fast and poorly tolerated
wide QRS tachycardia occurring in the early phase of myocar-
dial infarction is a ventricular tachycardia seems reasonable. A
2:1 atrial ﬂutter with aberrant conduction could mimic a
sustained monomorphic ventricular tachycardia, but this ar-
rhythmia would have had a frequency of 150 beats/min and
probably would have been well tolerated. The presence of
atrial tachycardia with aberrant conduction and poor hemody-
namic tolerance in the acute phase of myocardial infarction is
very uncommon, and it is highly unlikely that any of these
patients suffered from this arrhythmia.
Conclusions. Sustained monomorphic ventricular tachy-
cardia occurring in the acute phase of myocardial infarction is
a marker of extensive myocardial infarction associated with a
high in-hospital mortality. This fact would probably warrant
more aggressive diagnostic and therapeutic interventions and a
longer stay in the CCU. Mortality and morbidity in patients
with sustained monomorphic ventricular tachycardia during
follow-up were high but generally not related to arrhythmic
events.
We thank Irene Moral for assistance with the statistical analysis.
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